Daiwa Securities Group Inc. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$15,000
+114.3%
2140.0%0.00%
Q2 2022$7,0000.0%2140.0%0.00%
Q1 2022$7,000
+16.7%
2140.0%0.00%
Q4 2021$6,000
+20.0%
2140.0%0.00%
Q3 2021$5,000
+25.0%
214
+84.5%
0.00%
Q2 2021$4,000
-20.0%
1160.0%0.00%
Q1 2021$5,0000.0%1160.0%0.00%
Q4 2020$5,000
-73.7%
116
-66.7%
0.00%
Q3 2020$19,000
+11.8%
348
+2.4%
0.00%
Q2 2020$17,0000.0%3400.0%0.00%
Q1 2020$17,000
-37.0%
3400.0%0.00%
Q4 2019$27,000
+42.1%
340
-11.0%
0.00%
Q3 2019$19,0000.0%382
+6.7%
0.00%
Q2 2019$19,0000.0%3580.0%0.00%
Q1 2019$19,000
+90.0%
358
+48.5%
0.00%
Q4 2018$10,000
+11.1%
2410.0%0.00%
Q3 2018$9,000
-18.2%
2410.0%0.00%
Q2 2018$11,000
-8.3%
2410.0%0.00%
Q1 2018$12,0002410.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders